SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-071795
Filing Date
2021-05-25
Accepted
2021-05-25 16:13:51
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2117446-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2117446-4_4seq1.xml 4 4309
  Complete submission text file 0001104659-21-071795.txt   5979
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, STE. 250 AUSTIN TX 78746
Business Address
Rojas-Caro Sandra (Reporting) CIK: 0001674975 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 21960751